CiMaas
Pre-clinicalDevelops cell-based immunotherapies using proprietary macrophage technology for cancer treatment.
Founded
2016
Focus
Cell & Gene Therapy
About
Develops cell-based immunotherapies using proprietary macrophage technology for cancer treatment.
Funding History
2Total raised: $18.2M
Series A$15MYsios CapitalFeb 15, 2023
Seed$3.2MBioGeneration VenturesMay 15, 2021
Company Info
TypePrivate
Founded2016
LocationMaastricht, Netherlands
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile